申请人:Stangeland Eric
公开号:US20110009465A1
公开(公告)日:2011-01-13
In one aspect, the invention relates to compounds of formula I:
where R
1-6
are as defined in the specification, or a pharmaceutically acceptable salt thereof. The compounds of formula I are serotonin and norepinephrine reuptake inhibitors. In another aspect, the invention relates to pharmaceutical compositions comprising such compounds; methods of using such compounds; and process and intermediates for preparing such compounds.
在一个方面,该发明涉及公式I的化合物:其中R1-6如规范中定义,或其药用盐。公式I的化合物是血清素和去甲肾上腺素再摄取抑制剂。在另一个方面,该发明涉及包含这种化合物的药物组合物;使用这种化合物的方法;以及制备这种化合物的过程和中间体。